About Seagull BioSolutions
Seagull BioSolutions is a company based in Pune (India) founded in 2011 by Shruti Vishwas Joshi. Seagull BioSolutions has raised $126.67 thousand across 5 funding rounds from investors including ICICI Bank, Department of Scientific and Industrial Research and Startups at Venture Center. Seagull BioSolutions offers products and services including eSAME Technology and Active Virosome Technology. Seagull BioSolutions operates in a competitive market with competitors including Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
- Headquarter Pune, India
- Founders Shruti Vishwas Joshi
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Seagull Biosolutions Private Limited
- Date of Incorporation 06 May, 2011
- Jurisdiction Pune City, Maharashtra, India
-
Annual Revenue
$253.01 K (USD)256.39as on Mar 31, 2023
-
Net Profit
$107.77 K (USD)333.53as on Mar 31, 2023
-
EBITDA
$108.2 K (USD)867.61as on Mar 31, 2023
-
Total Equity Funding
$126.67 K (USD)
in 5 rounds
-
Latest Funding Round
Not available
-
Investors
ICICI Bank
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Seagull BioSolutions
Seagull BioSolutions offers a comprehensive portfolio of products and services, including eSAME Technology and Active Virosome Technology.
Develops healthcare products using innovative biological methods.
Advances virosome-based solutions for affordable medical applications.
Funding Insights of Seagull BioSolutions
Seagull BioSolutions has successfully raised a total of $126.67K across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Seagull BioSolutions
Seagull BioSolutions has secured backing from 8 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include ICICI Bank, Department of Scientific and Industrial Research and Startups at Venture Center.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startups are incubated at Venture Center, backed by CSIR.
|
Locked | Locked | Locked | |
|
Startup incubator focused on science business
|
Locked | Locked | Locked | |
|
Commercial bank
|
Locked | Locked | Locked |
Investor details for Seagull BioSolutions
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Seagull BioSolutions
Investment portfolio details for Seagull BioSolutions
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Seagull BioSolutions
Detailed financials for Seagull BioSolutions
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Seagull Biosolutions Comparisons
Peer comparison for Seagull BioSolutions
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Seagull BioSolutions
Seagull BioSolutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases are developed to treat patients.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| Locked | Locked | Locked |
Provider of cell therapies to treat cancer and hematologic conditions
|
Detailed competitors of Seagull BioSolutions
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Seagull Biosolutions
Complete news archive for Seagull BioSolutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Seagull BioSolutions
Seagull BioSolutions was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Seagull BioSolutions is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Seagull BioSolutions is a funded company, having raised a total of $126.67K across 5 funding rounds to date.
Annual revenue of Seagull BioSolutions is $253.01K as on Mar 31, 2023.
Founded in 2011 in Pune, India, Seagull BioSolutions operates in the biotechnology sector. A mammalian expression system known as eSAME technology is utilized by the company for producing recombinant proteins, viral vaccines, therapeutic agents, and gene therapy components. An oncolytic virus candidate, SBPL-0100, is being advanced to target prostate and other cancer cells selectively. Virosomes for dengue vaccines are also under development.
Seagull BioSolutions's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
Seagull BioSolutions offers eSAME Technology and Active Virosome Technology.
Seagull BioSolutions has 8 investors. Key investors include ICICI Bank, Department of Scientific and Industrial Research, Startups at Venture Center, Venture Center, and Shailendra Maheshwari.
The valuation of Seagull BioSolutions is $84.85K as of Mar 2012.